ational PROspective infrastructure for Renal Cell Carcinoma
Recruiting
- Conditions
- kidney cancerrenal cell carcinoma10038364
- Registration Number
- NL-OMON56090
- Lead Sponsor
- Stichting PRO-RCC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 10000
Inclusion Criteria
• Histologically proven RCC or mRCC or high clinical suspicion
• Age >= 18 years at time of inclusion
• Written informed consent
• Able to read and understand the patient information
Exclusion Criteria
None
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>This efficient and unique infrastructure for RCC research creates a facility,<br /><br>that will yield detailed insights in RCC disease aspects and treatment in the<br /><br>Netherlands and enable improved patient accrual in clinical trials. Ultimately,<br /><br>this will lead to an introduction of improved new treatment options in daily<br /><br>clinical practice. Furthermore, the collected data on HRQoL, symptoms and<br /><br>clinical management from diagnosis to death will result in robust *real-world*<br /><br>patient data. Data from patients who undergo registered and experimental<br /><br>therapies can be studied to answer relevant questions on relapse and<br /><br>progression to invasive or metastatic disease, and on optimal (sequencing of)<br /><br>treatment regimens and HRQoL as part of the decision making.</p><br>
- Secondary Outcome Measures
Name Time Method <p>n/a</p><br>